Bob van Gemen PhD


Bob joined the GenDx board in August 2021 and is on the board of several other biotech companies. Until January 2021 he was the CEO of Viroclinics-DDL and before that was working for Philips starting their digital pathology business. Prior to this Bob was CEO at Primagen, an Amsterdam-based diagnostics company. Bob has a PhD in molecular biology from the university of Leiden.